(Q73943042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

Y Heike

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Takahashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Ohira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

I Naruse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Hama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Y Ohe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Kasai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H Fukumoto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

K J Olsen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E E Podack

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

N Saijo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

844-849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Inpatient continuous-infusion interleukin-2 in 788 patients with cancer. The National Biotherapy Study Group experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819971210%2973%3A6%3C844%3A%3AAID-IJC14%3E3.0.CO%3B2-4

10.1002/(SICI)1097-0215(19971210)73:6<844::AID-IJC14>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9399664%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference